Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 9.49B P/E 57.59 EPS this Y -17.10% Ern Qtrly Grth -92.70%
Income 14.84M Forward P/E 65.32 EPS next Y 38.60% 50D Avg Chg 7.00%
Sales 607.45M PEG 6.77 EPS past 5Y 9.75% 200D Avg Chg -
Dividend N/A Price/Book 4.89 EPS next 5Y 17.11% 52W High Chg -35.00%
Recommedations 1.90 Quick Ratio 5.03 Shares Outstanding 55.88M 52W Low Chg 27.00%
Insider Own 6.58% ROA 0.60% Shares Float 52.05M Beta 1.01
Inst Own 105.56% ROE 0.76% Shares Shorted/Prior 4.59M/4.77M Price 170.48
Gross Margin 47.64% Profit Margin 2.44% Avg. Volume 612,325 Target Price 204.58
Oper. Margin 1.34% Earnings Date Jul 31 Volume 1,177,969 Change 2.01%
About Repligen Corporation

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Repligen Corporation News
06:30 AM Repligen Corporation to Present at Upcoming May Investor Conferences
05/03/24 Repligen First Quarter 2024 Earnings: EPS Misses Expectations
05/02/24 Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript
05/02/24 Repligen (RGEN) Q1 Earnings Miss, Revenues Beat Estimates
05/02/24 Repligen Corp (RGEN) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Shifts and ...
05/01/24 Repligen Corp (RGEN) Q1 2024 Earnings: A Close Alignment with Analyst Projections
05/01/24 Repligen (RGEN) Misses Q1 Earnings Estimates
05/01/24 Repligen Reports First Quarter 2024 Financial Results
04/23/24 Should be Confident in Repligen Corporation (RGEN)’s Long-Term Growth Potential?
04/17/24 Repligen to Report First Quarter 2024 Financial Results
04/12/24 Artisan Mid Cap Fund Trimmed Repligen Corporation (RGEN) after Share Appreciation
03/19/24 Repligen Appoints Maggie A. Pax to Board of Directors
03/18/24 Are Repligen Corporation's (NASDAQ:RGEN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
03/12/24 Repligen Corp CEO Anthony Hunt Sells 16,707 Shares
03/04/24 PBYI vs. RGEN: Which Stock Is the Better Value Option?
02/27/24 Repligen Corp COO James Bylund Sells 4,373 Shares
02/26/24 Estimating The Fair Value Of Repligen Corporation (NASDAQ:RGEN)
02/24/24 Decoding Repligen Corp (RGEN): A Strategic SWOT Insight
02/22/24 Repligen Corporation (NASDAQ:RGEN) Q4 2023 Earnings Call Transcript
02/22/24 Repligen (RGEN) Stock Down on Q4 Earnings Miss, Revenues Fall Y/Y
RGEN Chatroom

User Image DonCorleone77 Posted - 6 days ago

$RGEN Repligen reports Q1 adjusted EPS 28c, consensus 30c Reports Q1 revenue $151.346M, consensus $150.06M. Tony Hunt, Chief Executive Officer of Repligen said, "We delivered a solid first quarter, with revenue of $151 million and are on track to achieving our first half sales target of $300 to $310 million. For the quarter, our book-to-bill ratio was 0.99 and over the past nine months we achieved a book-to-bill of 1.03; indicative that our markets are recovering, albeit slowly. On a franchise level, our Filtration franchise excluding COVID delivered double-digit revenue growth, both sequentially and year-over-year. Our latest acquisition - Metenova - continued to achieve both revenue and orders targets. We also saw continued strength from new modality customers who are scaling up with our technologies. All in, we're pleased with our first quarter performance and we are holding our adjusted 2024 financial guidance, continuing to expect that orders will pick up during the second half of the year."

User Image epsguid Posted - 6 days ago

$RGEN reported earnings of $0.28, consensus was $0.29 via @eWhispers #epsmiss http://eps.sh/d/rgen

User Image Stock_Titan Posted - 6 days ago

$RGEN Repligen Reports First Quarter 2024 Financial Results https://www.stocktitan.net/news/RGEN/repligen-reports-first-quarter-2024-financial-phn1ryp8d57m.html

User Image basscat12 Posted - 04/18/24

$LAC $RGEN $LVS Pre-Market Gap Down, delayed, courtesy barchart, presented here for @Vegas1 to hel[ follow the money! Pretty slim!

User Image Stock_Titan Posted - 04/17/24

$RGEN Repligen to Report First Quarter 2024 Financial Results https://www.stocktitan.net/news/RGEN/repligen-to-report-first-quarter-2024-financial-y56lts54uu95.html

User Image Aigner_Andreas Posted - 1 month ago

TD BUY $RGEN at 173.81, Supp 172.94 Resis 199.74 R15 HiLo 63% T1Y 264 buy 1.7 DIV N/A #Repligen C #stocks #trading #finance #market

User Image insiderbuyingselling Posted - 03/13/24

$RGEN new insider selling: 3517 shares. http://insiderbuyingselling.com/?t=RGEN

User Image insiderbuyingselling Posted - 03/12/24

$RGEN new insider selling: 16707 shares. http://insiderbuyingselling.com/?t=RGEN

User Image insiderbuyingselling Posted - 02/29/24

$RGEN new insider selling: 1000 shares. http://insiderbuyingselling.com/?t=RGEN

User Image insiderbuyingselling Posted - 02/27/24

$RGEN new insider selling: 4373 shares. http://insiderbuyingselling.com/?t=RGEN

User Image IN0V8 Posted - 02/22/24

$RGEN Jefferies raises target price to $180 from $148 JP Morgan raises target price to $230 from $210 Leerink Partners raises target price to $215 from $195 RBC raises target price to $225 from $200 Stifel raises target price to $207 from $165

User Image swingingtech Posted - 02/21/24

$RGEN https://wallstreetwaves.com/whats-going-on-with-life-science-focused-repligen-stock-today/

User Image OpenOutcrier Posted - 02/21/24

$RGEN (-7.4% pre) Repligen Corp (RGEN) Reports Decline in 2023 Revenue and Net Income - gurufocus https://ooc.bz/l/25579

User Image DonCorleone77 Posted - 02/21/24

$RGEN Regeneron sees FY24 adjusted EPS $1.42-$1.49, consensus $1.77 Sees FY24 revenue $620M-$650M, consensus $660.71M

User Image DonCorleone77 Posted - 02/21/24

$RGEN Repligen reports Q4 adjusted EPS 33c, consensus 33c Reports Q4 revenue $155.7M, consensus $155.39M. Tony Hunt, Chief Executive Officer of Repligen said, "During the fourth quarter, we again saw order strength, driven by our Filtration and Analytics franchises and continued momentum from new modality accounts, which reflects the differentiated nature of our products in this market. We are pleased to report that for the second quarter in a row, our book-to-bill ratio was above 1.0, at 1.03 for the fourth quarter. Revenue for the quarter came in as expected with a nice contribution from Metenova of $5 million, very much in-line with our expectations. While there are still pockets of headwinds and challenging macro factors in China, we remain optimistic that our markets will improve as we advance through 2024, with growth accelerating in the second half of the year."

User Image epsguid Posted - 02/21/24

$RGEN reported earnings of $0.33, consensus was $0.33 via @eWhispers #epsmeet http://eps.sh/d/rgen

User Image Stock_Titan Posted - 02/21/24

$RGEN Repligen Reports Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/RGEN/repligen-reports-fourth-quarter-and-full-year-2023-financial-8b4psj3hxax2.html

User Image PrecisionTactical Posted - 02/20/24

@ianleung @Bigbossmann probably by $RGEN. Wishful thinking though lol

User Image StockInvest_us Posted - 02/16/24

Signal alert: $RGEN - Overbought Trend Short (Overvalued) https://stockinvest.us/l/DQzGz7pYnR

User Image MateuszTrades Posted - 02/09/24

$RGEN $250 by June

User Image Stock_Titan Posted - 3 months ago

$RGEN Repligen to Report Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/RGEN/repligen-to-report-fourth-quarter-and-full-year-2023-financial-p319xct2z542.html

User Image chartsmarter Posted - 01/30/24

Biotech Boogie: https://www.chartsmarter.com/2024/01/30/healthcare-sector-review-1-31-24/ "full note up here (once a month). $XBI WEEKLY chart shooting for par into end of Q1. $INSM acting technically sound. $RGEN holding 200 WEEK SMA. $RVMD not shying away from upside gap fill. $IOVA wants double-digits near term." #biotech

User Image AnchorsAweigh Posted - 01/26/24

$RGEN looks like a potential biotech leader. Big breakout today on volume. Fresh monthly MACD cross

User Image quantcha Posted - 01/26/24

Big Gainer Alert: Trading today's 7.0% move in REPLIGEN $RGEN https://ideas.quantcha.com/?p=81557

User Image AnthonyKingsmill Posted - 01/26/24

$RGEN $T Started trading over 4 months ago and I lost $3K. Now I've made over $177K+ profits after joining their chat room and using their alerts. Highly recommended! It's free joining>> https://main-stock-trading-chatplatform.topmarketwatch.vip

User Image StockAutomatePro Posted - 01/24/24

$RGEN Chart analysis confirms an upward trend for the stock. We alerted the BUY signal at $171.2 and we were able to close this one with profit at $187.15🤙

User Image cctranscripts Posted - 01/23/24

BlackRock, Inc. just provided an update on share ownership of Repligen Corporation https://www.conferencecalltranscripts.org/summary/?id=12886972 $RGEN

User Image tickeron Posted - 01/23/24

Oh wow this is big! $RGEN price may drop as it broke higher Bollinger Band. View odds of downtrend. https://srnk.us/go/4976848

User Image StockAutomatePro Posted - 01/22/24

$RGEN The chart is indicating an upward trend for the stock. We alerted the BUY signal at $171 and we were able to close this one with profit at $184.225 ✅

User Image TrendyChart Posted - 01/20/24

$RGEN The symphony of technical signals plays harmoniously on the stock chart, orchestrating a melody of potential gains and a steadfast trend that leads to success. 💹 https://trendychart.lpages.co/options/

Analyst Ratings
JP Morgan Overweight May 2, 24
Stifel Buy Feb 22, 24
Keybanc Overweight Feb 15, 24
JP Morgan Overweight Dec 20, 23
Benchmark Hold Dec 4, 23
UBS Buy Nov 2, 23
Stifel Buy Nov 1, 23
RBC Capital Outperform Nov 1, 23
Keybanc Overweight Nov 1, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Gebski Christine See Remarks See Remarks Nov 10 Sell 147.13 3,788 557,328 28,787 11/13/23
Madaus Martin D Director Director Mar 24 Buy 158.84 1,500 238,260 1,611 05/08/23
EGLINTON MANNER CARRIE Director Director Mar 16 Buy 175.02 625 109,388 2,106 12/15/22
Hunt Anthony Chief Executive Offi.. Chief Executive Officer Nov 11 Option 33.87 25,000 846,750 203,265 11/14/22
Hunt Anthony Chief Executive Offi.. Chief Executive Officer Nov 11 Sell 200 25,000 5,000,000 178,265 11/14/22
DAWES KAREN A Director Director Sep 09 Sell 227.17 775 176,057 76,401 09/09/22
Hunt Anthony Chief Executive Offi.. Chief Executive Officer Sep 08 Option 33.87 10,000 338,700 204,667 09/09/22
Hunt Anthony Chief Executive Offi.. Chief Executive Officer Sep 08 Sell 223.76 26,402 5,907,712 178,265 09/09/22
Snodgres Jon Chief Financial Offi.. Chief Financial Officer Aug 01 Sell 220.00 2,000 440,000 37,187 08/02/22
DAWES KAREN A Director Director May 25 Sell 151.1 14,715 2,223,436 76,532 05/26/22
Snodgres Jon Chief Financial Offi.. Chief Financial Officer Mar 08 Option 46.7 4,166 194,552 39,899 03/09/22
RYAN THOMAS F JR Director Director Mar 01 Option 38.76 1,000 38,760 3,457 03/02/22
RYAN THOMAS F JR Director Director Mar 01 Sell 198.03 2,000 396,060 1,457 03/02/22
RYAN THOMAS F JR Director Director Nov 02 Option 128.18 1,285 164,711 14,622 11/04/21
RYAN THOMAS F JR Director Director Nov 02 Sell 295 2,285 674,075 12,337 11/04/21
DAWES KAREN A Director Director Nov 02 Sell 303.19 2,400 727,656 91,247 11/04/21
DAWES KAREN A Director Director Sep 15 Sell 293.45 274 80,405 93,647 09/15/21
Hunt Anthony Chief Executive Offi.. Chief Executive Officer Sep 13 Sell 295.45 25,000 7,386,250 189,495 09/13/21
Hunt Anthony Chief Executive Offi.. Chief Executive Officer Sep 13 Option 32.4 25,000 810,000 214,495 09/13/21
DAWES KAREN A Director Director Aug 19 Sell 256.52 18,956 4,862,593 93,921 08/19/21
KURIYEL RALF Senior VP, R&D Senior VP, R&D Jun 14 Option 72.81 3,602 262,262 28,157 06/14/21
DAWES KAREN A Director Director May 13 Option 3.22 15,000 48,300 115,734 05/13/21
DAWES KAREN A Director Director May 13 Sell 176.85 285 50,402 115,449 05/13/21
Hunt Anthony Chief Executive Offi.. Chief Executive Officer Mar 08 Sell 191.48 21,900 4,193,412 221,864 03/08/21
Snodgres Jon Chief Financial Offi.. Chief Financial Officer Mar 08 Sell 193.15 3,545 684,717 32,363 03/08/21
KURIYEL RALF Senior VP, R&D Senior VP, R&D Mar 08 Sell 192.81 2,075 400,081 25,265 03/08/21
RYAN THOMAS F JR Director Director Mar 04 Option 26.12 1,000 26,120 2,464 03/04/21
RYAN THOMAS F JR Director Director Mar 04 Sell 205 1,000 205,000 1,464 03/04/21
Hunt Anthony Chief Executive Offi.. Chief Executive Officer Nov 23 Option 26.05 20,000 521,000 253,327 11/23/20
Hunt Anthony Chief Executive Offi.. Chief Executive Officer Nov 23 Sell 186.12 20,000 3,722,400 233,327 11/23/20
Snodgres Jon Chief Financial Offi.. Chief Financial Officer Nov 10 Option 45.96 4,979 228,835 36,541 11/10/20
Snodgres Jon Chief Financial Offi.. Chief Financial Officer Nov 10 Sell 193.85 3,791 734,885 33,455 11/10/20